| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/09/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 12k | $40.38 | $484.6k | | 10/09/2023 |
| 10/09/2023 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 18.5k | $2.67 | $49.4k | | 10/09/2023 |
| 08/08/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 12k | $23.66 | $283.9k | | 08/08/2023 |
| 08/08/2023 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 18.5k | $2.67 | $49.4k | | 08/08/2023 |
| 07/10/2023 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 18.5k | $2.67 | $49.4k | | 07/10/2023 |
| 07/10/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 12k | $84.55 | $1M | | 07/10/2023 |
| 06/08/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 12k | $91.35 | $1.1M | | 06/08/2023 |
| 06/08/2023 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 18.5k | $2.67 | $49.4k | | 06/08/2023 |
| 05/08/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 12k | $92.39 | $1.1M | | 05/08/2023 |
| 05/08/2023 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 18.5k | $2.67 | $49.4k | | 05/08/2023 |
| 03/08/2023 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 18.5k | $2.67 | $49.4k | | 03/08/2023 |
| 03/08/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 12k | $63.79 | $765.5k | | 03/08/2023 |
| 02/21/2023 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Common Stock | 9.9k | $0.00 | $0 | | 02/21/2023 |
| 02/21/2023 | Apellis Pharmaceuticals, Inc. | APLS | Payment of Exercise | Common Stock | 1.2k | $58.50 | $69.9k | | 02/21/2023 |
| 02/21/2023 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock Option (Right to Buy) | 14k | $35.46 | $497.3k | | 02/21/2023 |
| 01/27/2023 | Apellis Pharmaceuticals, Inc. | APLS | Payment of Exercise | Common Stock | 832 | $52.77 | $43.9k | | 01/27/2023 |
| 01/20/2023 | Apellis Pharmaceuticals, Inc. | APLS | Payment of Exercise | Common Stock | 2.3k | $52.05 | $121.1k | | 01/20/2023 |
| 01/09/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 12k | $46.08 | $553k | | 01/09/2023 |
| 01/09/2023 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 18.5k | $2.67 | $49.4k | | 01/09/2023 |
| 12/29/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 7k | $3.67 | $25.7k | | 12/29/2022 |
| 12/08/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 12k | $47.50 | $570k | | 12/08/2022 |
| 12/08/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 18.5k | $2.67 | $49.4k | | 12/08/2022 |
| 10/10/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 12k | $57.50 | $690k | | 10/10/2022 |
| 10/10/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 18.5k | $2.67 | $49.4k | | 10/10/2022 |
| 09/08/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 12k | $63.98 | $767.8k | | 09/08/2022 |
| 09/08/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 18.5k | $2.67 | $49.4k | | 09/08/2022 |
| 07/08/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 12k | $47.95 | $575.4k | | 07/08/2022 |
| 07/08/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 12k | $2.67 | $32k | | 07/08/2022 |
| 07/08/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 6.5k | $2.67 | $17.4k | | 07/08/2022 |
| 06/17/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 33k | $2.67 | $88.1k | | 06/17/2022 |
| 06/08/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 6.5k | $2.67 | $17.4k | | 06/08/2022 |
| 06/08/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 12k | $2.67 | $32k | | 06/08/2022 |
| 06/08/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 12k | $44.09 | $529.1k | | 06/08/2022 |
| 04/29/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 4k | $44.43 | $177.7k | | 04/21/2022 |
| 04/29/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 4k | $2.67 | $10.7k | | 04/21/2022 |
|